Neopenda
Neopenda: Innovating essential medical technologies for emerging high-growth markets.
Neopenda: Innovating essential medical technologies for emerging high-growth markets.
Neopenda, founded with a mission to innovate essential medical technologies for emerging high-growth markets, focuses on creating solutions tailored to the unique challenges of resource-constrained health facilities. Their flagship product, neoGuard, is a wearable vital signs monitor designed to improve patient outcomes in areas with limited access to reliable medical equipment. By addressing issues such as power instability and internet access, Neopenda aims to enhance healthcare delivery and accessibility for underserved populations.
Notable individuals affiliated with Neopenda include its co-founders Sona Shah and Teresa Cauvel, who bring expertise in biomedical engineering and global health. The company has garnered support from prominent investors and organizations, including the Bill & Melinda Gates Foundation and Grand Challenges Canada. Neopenda's innovative approach has led to significant achievements, such as successful clinical trials and partnerships with healthcare providers in various emerging markets. Their impact is evident in the improved healthcare outcomes and increased access to vital medical technologies in underserved regions.
Companies similar to Neopenda include NeVap, Somnea Health, Apex Neuro and Denali Medical.
Neopenda was founded in 2015.
Neopenda's headquarters is located in Chicago, IL, US.
Neopenda's most recent funding round was for $700k (USD) in September 2022.
As of Sep 1, 2022, Neopenda has disclosed funding of $4.2M (USD). Undisclosed round amounts are excluded.
Neopenda has 75 employees as of Feb 4, 2024.
denalimedical.com
